Business Context and Reporting Period
This Form 8-K is filed by Atlantic Technology Ventures, Inc. (not TG Therapeutics, Inc.) with a report date of December 28, 2000. The filing addresses "Other Events" regarding an amendment to a stock repurchase agreement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate transaction involving equity.
Material Changes
- Stock Repurchase Agreement Amendment: On December 28, 2000, the Company amended a Stock Repurchase Agreement originally entered into on December 4, 2000, with BH Capital Investments, L.P. and Excalibur Limited Partnership.
- Expiration Date Extension: The amendment extended the expiration date of the Company's option to repurchase shares from January 2, 2001, to January 9, 2001.
- Shares Involved: The option covers the remaining 206,898 shares of Atlantic's Series B convertible preferred stock held by the Investors.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of general risks. The primary contingency noted is the time-sensitive nature of the repurchase option, which now expires on January 9, 2001.
Investor Verification Checklist
- Verify the final status of the repurchase option for the 206,898 Series B shares after the January 9, 2001 deadline.
- Review the original Stock Purchase Agreement (Exhibit 10.1 to the December 11, 2000 Form 8-K) to understand the specific repurchase terms.
- Confirm the current ownership structure of Atlantic Technology Ventures, Inc. following this transaction.